IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management II, LLC

Q3 2019 Holdings

Filed 2019-11-13 | 7 holdings | $473.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
10x Genomics, Inc.(TXG)CLASS A COMMON88025U109$344.6K6,837,25372.9%
Aimmune Therapeutics, Inc.(AIMT)COM00900T107$54.6K2,605,49911.5%
Aerie Pharmaceuticals, Inc.(AERIEUR)COM00771V108$32.2K1,672,7146.8%
Insmed Incorporated(INSM)COM457669307$16.1K915,0163.4%
Epizyme, Inc.(EPZMEUR)COM29428V104$15.4K1,488,4443.2%
Acceleron Pharma Inc.(XLRN)COM00434H108$7.5K188,6021.6%
Alder BioPharmaceuticals, Inc.(ALDR1EUR)COM014339105$2.8K146,8000.6%